COM:HILLEVAX
HilleVax, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalswebsite
hillevax.comcrunchbase
hillevaxlinkedin
hillevaxfounding date
Jan 01, 2021ipo date
Apr 29, 2022
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.